These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 9032338)

  • 1. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues.
    Wong JK; Ignacio CC; Torriani F; Havlir D; Fitch NJ; Richman DD
    J Virol; 1997 Mar; 71(3):2059-71. PubMed ID: 9032338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.
    Quiñones-Mateu ME; Albright JL; Mas A; Soriano V; Arts EJ
    J Virol; 1998 Nov; 72(11):9002-15. PubMed ID: 9765445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syncytium-inducing phenotype and zidovudine susceptibility of HIV-1 isolated from post-mortem tissue.
    McGavin CH; Land SA; Sebire KL; Hooker DJ; Gurusinghe AD; Birch CJ
    AIDS; 1996 Jan; 10(1):47-53. PubMed ID: 8924251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
    Cornelissen M; van den Burg R; Zorgdrager F; Lukashov V; Goudsmit J
    J Virol; 1997 Sep; 71(9):6348-58. PubMed ID: 9261352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes.
    Mason RD; Bowmer MI; Howley CM; Gallant M; Myers JC; Grant MD
    J Immunol; 2004 Jun; 172(11):7212-9. PubMed ID: 15153547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative differences in the distribution of zidovudine resistance mutations in multiple post-mortem tissues from AIDS patients.
    Atkins M; Strappe P; Kaye S; Loveday C; McLaughlin JE; Johnson MA; Tedder RS; Griffiths PD; Emery VC
    J Med Virol; 1998 Jun; 55(2):138-46. PubMed ID: 9598935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy.
    Ball JK; Holmes EC; Whitwell H; Desselberger U
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():67-79. PubMed ID: 8151287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance.
    Loemba H; Brenner B; Parniak MA; Ma'ayan S; Spira B; Moisi D; Oliveira M; Detorio M; Essex M; Wainberg MA
    Antiviral Res; 2002 Nov; 56(2):129-42. PubMed ID: 12367719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells.
    Haddad DN; Birch C; Middleton T; Dwyer DE; Cunningham AL; Saksena NK
    AIDS; 2000 Oct; 14(15):2273-81. PubMed ID: 11089615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
    Stephens EB; Liu ZQ; Zhu GW; Adany I; Joag SV; Foresman L; Berman NE; Narayan O
    Virology; 1995 Nov; 213(2):600-14. PubMed ID: 7491784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
    Shafer RW; Eisen JA; Merigan TC; Katzenstein DA
    J Virol; 1997 Jul; 71(7):5441-8. PubMed ID: 9188616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
    Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
    Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.
    Gurusinghe AD; Land SA; Birch C; McGavin C; Hooker DJ; Tachedjian G; Doherty R; Deacon NJ
    J Med Virol; 1995 Jul; 46(3):238-43. PubMed ID: 7561796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.
    Goudsmit J; de Ronde A; de Rooij E; de Boer R
    J Virol; 1997 Jun; 71(6):4479-84. PubMed ID: 9151839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of human immunodeficiency virus type 1 subtype E (CRF01_AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase.
    Sato H; Tomita Y; Ebisawa K; Hachiya A; Shibamura K; Shiino T; Yang R; Tatsumi M; Gushi K; Umeyama H; Oka S; Takebe Y; Nagai Y
    J Virol; 2001 Jun; 75(12):5604-13. PubMed ID: 11356968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy.
    Sheehy N; Desselberger U; Whitwell H; Ball JK
    J Gen Virol; 1996 May; 77 ( Pt 5)():1071-81. PubMed ID: 8609473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences.
    Yahi N; Tamalet C; Tourrès C; Tivoli N; Ariasi F; Volot F; Gastaut JA; Gallais H; Moreau J; Fantini J
    J Clin Microbiol; 1999 Dec; 37(12):4099-106. PubMed ID: 10565938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
    Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.
    Hooker DJ; Tachedjian G; Solomon AE; Gurusinghe AD; Land S; Birch C; Anderson JL; Roy BM; Arnold E; Deacon NJ
    J Virol; 1996 Nov; 70(11):8010-8. PubMed ID: 8892925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies.
    Sato H; Tomita Y; Shibamura K; Shiino T; Miyakuni T; Takebe Y
    J Virol; 2000 Jun; 74(11):5357-62. PubMed ID: 10799614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.